AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19714604
Drug: Belimumab (1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Belimumab (1, 4, or 10 mg/kg)
Trial: 9784084
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg/day for 6 days
Trial: 7929869
Drug: CL 275,838
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CL 275,838 (50 mg)
Trial: 7929869
Drug: CL 275,838
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CL 275,838 (100 mg)
Trial: 30591703
Drug: C₁‐L protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C₁‐L protocol group (n=293)
Trial: 30591703
Drug: OC‐L protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OC‐L protocol group (n=91)
Trial: 30591703
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist protocol group (n=80)
Trial: 27152422
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg of IV dexamethasone before general anesthesia, BIS 35-45
Trial: 27152422
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg of IV dexamethasone before general anesthesia, BIS 46-55
Trial: 24717957
Drug: Electrolyzed acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrolyzed acid water (EAW) nasal irrigation daily for 2 months
Trial: 24717957
Drug: Neutral normal
RxNorm normalized name: DentiCare Neutral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutral normal saline (NS) nasal irrigation daily for 2 months
Trial: 21996342
Drug: High-dose allergen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose allergen patches
Trial: 15892409
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of i.v. lidocaine and nitrous oxide in oxygen inhalation
Trial: 15892409
Drug: Nitrous oxide
RxNorm normalized name: Nitrous Oxide
DrugBank: Nitrous oxide (DB06690)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitrous oxide in oxygen inhalation
Trial: 8941648
Drug: GBS type
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GBS type III CPS‐tetanus toxoid conjugate (III‐TT) vaccine (highest dose)
Trial: 6313595
Drug: Oral acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral acyclovir 200 mg every 6 hours from day 8 to day 35 after transplantation
Trial: 27333284
Drug: ivabradine 2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ivabradine 2.5, 5, or 7.5 mg b.i.d. for 4 months
Trial: 22606977
Drug: Peer support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peer support intervention (biweekly visits for 2 months, then weekly)
Trial: 22606977
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care (adherence counselling, monthly health check, drug refills)
Trial: 20958200
Drug: Web-based self-administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based self-administered questionnaire (Web SAQ)
Trial: 20958200
Drug: Paper-and-pencil self-administered
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paper-and-pencil self-administered questionnaire
Trial: 17066232
Drug: Intra-arterial adjuvant
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial adjuvant chemotherapy with cisplatin (CDDP) and 5-fluorouracil (5FU)
Trial: 17066232
Drug: Intra-arterial adjuvant
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial adjuvant chemotherapy
Trial: 15750369
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (flexion‐distraction chiropractic manipulation and trigger point therapy)
Trial: 15750369
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (sham manipulation and effleurage)
Trial: 4097650
Drug: Combined preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined preparation of triiodothyronine and thyroxine (1:4 ratio)
Trial: 30861580
Drug: Galcanezumab (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galcanezumab (120 mg and 240 mg)
Trial: 28113032
Drug: Letrozole (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole (2.5 mg once per day for 5 years)
Trial: 28113032
Drug: Anastrozole (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole (1 mg once per day for 5 years)
Trial: 23279614
Drug: Tacrolimus twice
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus twice daily (control)
Trial: 17250932
Drug: Zoster vaccine
RxNorm normalized name: ZOSTER VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zoster vaccine (approximately 50,000 PFU)
Trial: 10665552
Drug: Aspirin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (80 mg orally twice daily)
Trial: 10665552
Drug: Low-dose sibrafiban
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose sibrafiban (3.0 mg, 4.5 mg, or 6.0 mg)
Trial: 10665552
Drug: High-dose sibrafiban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose sibrafiban (3.0 mg, 4.5 mg, or 6.0 mg)
Trial: 10665552
Drug: High-dose sibrafiban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose sibrafiban
Trial: 10665552
Drug: Low-dose sibrafiban
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose sibrafiban
Trial: 9374092
Drug: Epirubicin 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin 75 mg/m2 as a 1-hour infusion followed by paclitaxel 200 mg/m2 as a 3-hour infusion every 3 weeks
Trial: 9374092
Drug: Epirubicin 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin 75 mg/m2 plus paclitaxel 200 mg/m2
Trial: 3884881
Drug: Protein excretion
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein excretion in transplant patients during pregnancy
Trial: 3884881
Drug: Protein excretion
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein excretion in healthy women during pregnancy
Trial: 27932335
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg apixaban, administered twice daily for 3 years as adjunct therapy to stable oral PAH therapy
Trial: 27932335
Drug: Placebo, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, administered twice daily for 3 years as adjunct therapy to stable oral PAH therapy
Trial: 17868539
Drug: Total dose
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total dose 4.5 g of azithromycin in 7 weeks
Trial: 17868539
Drug: Total dose
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total dose 6.0 g of azithromycin in 10 weeks
Trial: 17868539
Drug: Total dose
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total dose 7.5 g of azithromycin in 13 weeks
Trial: 15167314
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg 17beta‐estradiol + 0.125 mg trimegestone (n = 179)
Trial: 12851621
Drug: Lisinopril plus
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lisinopril plus isosorbide-5-mononitrate (IS5MN)
Trial: 12851621
Drug: Lisinopril plus
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lisinopril plus IS5MN
Trial: 1906258
Drug: Cefaclor (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor (20 to 40 mg/kg/day in three divided doses for 10 days)
Trial: 1906258
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V (50,000 to 100,000 IU/kg/day in three divided doses for 10 days)
Trial: 31350768
Drug: BDF +
RxNorm normalized name: LIME (CALCIUM OXIDE) 0.295 g in 100 mL ORAL SPRAY [BDFERM BIOSPRAY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BDF + Oi (manual brushing/dental flossing + oral irrigator)
Trial: 27505335
Drug: Intensive atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive atorvastatin (40mg)
Trial: 27505335
Drug: Standard atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard atorvastatin (20mg)
Trial: 16832679
Drug: gemfibrozil 600
RxNorm normalized name: gemfibrozil 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemfibrozil 600 mg orally twice daily for 3 days
Trial: 14563899
Drug: co-amoxiclav 2000/125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: co-amoxiclav 2000/125 mg twice daily
Trial: 14563899
Drug: co-amoxiclav 875/125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: co-amoxiclav 875/125 mg three times daily
Trial: 2255839
Drug: Ivermectin 100
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin 100 mcg/kg
Trial: 1519031
Drug: Diethylcarbamazine (DEC)
RxNorm normalized name: diethylcarbamazine
DrugBank: Diethylcarbamazine (DB00711)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diethylcarbamazine (DEC) 3 mg/kg
Trial: 1480807
Drug: Diethylcarbamazine (DEC)
RxNorm normalized name: diethylcarbamazine
DrugBank: Diethylcarbamazine (DB00711)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diethylcarbamazine (DEC) 3 mg/kg (3 successive semi-annual doses)
Trial: 6529168
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of trimipramine in the evening
Trial: 6529168
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of trimipramine three times daily
Trial: 22987022
Drug: Atomoxetine 80
RxNorm normalized name: atomoxetine 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine 80 mg daily followed by 100 mg daily for 5 days
Trial: 22987022
Drug: Atomoxetine 80
RxNorm normalized name: atomoxetine 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine 80 mg and 100 mg
Trial: 16270222
Drug: Single-dose clindamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose clindamycin (600 mg 1 hour before surgery)
Trial: 16270222
Drug: 24-hour clindamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour clindamycin prophylaxis (600 mg 1 hour before surgery, followed by 300 mg every 6 hours)
Trial: 12358676
Drug: Naloxone (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (intravenous bolus followed by continuous infusion)
Trial: 9697988
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous (Ci.v.) IL-2, n = 5
Trial: 9697988
Drug: Subcutaneous infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous infusions of polyethylene glycol-modified (PEG) IL-2, n = 7
Trial: 9697988
Drug: Anti-viral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-viral therapy alone, n = 4
Trial: 9697988
Drug: All treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All treatment arms (Ci.v. IL-2, PEG IL-2, anti-viral therapy)
Trial: 266407
Drug: Active immunotherapy
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active immunotherapy (AI)
Trial: 27810284
Drug: Control condition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control condition (treatment-as-usual)
Trial: 22952691
Drug: Internet-based guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based guided self-help problem-solving therapy (PST), consisting of 5 weekly lessons, supported by e-mail
Trial: 15127339
Drug: Miltefosine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miltefosine (2.5 mg/kg per day orally for 28 days)
Trial: 11868759
Drug: Telithromycin 800
RxNorm normalized name: Telithromycin
DrugBank: Telithromycin (DB00976)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telithromycin 800 mg once daily for 5 days (n = 198)
Trial: 11868759
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V 500 mg three times daily for 10 days (n = 197)
Trial: 7889960
Drug: Cefprozil 30
RxNorm normalized name: Cefprozil
DrugBank: Cefprozil (DB01150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefprozil 30 mg/kg/day (b.i.d.)
Trial: 7889960
Drug: Amoxicillin-clavulanate 40
RxNorm normalized name: amoxicillin-clavulanate 400 mg-57 mg oral tablet, chewable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanate 40 mg/kg/day (t.i.d.)
Trial: 7889960
Drug: Cefaclor 40
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor 40 mg/kg/day (t.i.d.)
Trial: 7889960
Drug: Cefixime 8
RxNorm normalized name: cefixime 8 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 8 mg/kg/day (q.d.)
Trial: 19939441
Drug: Diindolylmethane (DIM)
DrugBank: 3,3'-diindolylmethane (DB11875)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diindolylmethane (DIM) at approximately 2 mg/kg/day for 12 weeks
Trial: 6130952
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg cimetidine
Trial: 7586949
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg cimetidine
Trial: 7586949
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg cimetidine
Trial: 208429
Drug: theophylline-ephedrine combination
RxNorm normalized name: Theophylline, Ephedrine Hydrochloride, and Phenobarbital Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: theophylline-ephedrine combination (theophylline 90 mg, ephedrine 16 mg and phenobarbital 25 mg in an immediate release layer and theophylline 90 mg and ephedrine 32 mg in a sustained release layer)
Trial: 208429
Drug: terbutaline (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terbutaline (5 mg three times daily)
Trial: 17935764
Drug: 300-index of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300-index of reactivity (IR) dose
Trial: 17935764
Drug: 500-index of
RxNorm normalized name: Oil of peppermint
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500-index of reactivity (IR) dose
Trial: 17935764
Drug: 100-index of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100-index of reactivity (IR) dose
Trial: 15016256
Drug: 1% metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% metronidazole gel (MG, n=19)
Trial: 15016256
Drug: 1% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% chlorhexidine gel (CG, n=20)
Trial: 15016256
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel (PG, n=24)
Trial: 11716994
Drug: Continuous transdermal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous transdermal 17beta‐estradiol 50 mcg/die plus acetate nomegestrolo 5 mg/die sequentially added for 12 days per month (Group A)
Trial: 11716994
Drug: Continuous transdermal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous transdermal 17beta‐estradiol 50 mcg/die plus acetate nomegestrolo 2.5 mg/die added every day (Group B)
Trial: 11716994
Drug: Continuous transdermal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous transdermal 17beta‐estradiol 50 mcg/die (Group C)
Trial: 11716994
Drug: Tibolone 2.5
RxNorm normalized name: tibolone 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone 2.5 mg/die (Group D)
Trial: 11716994
Drug: No medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No medication (Control Group E)
Trial: 8021039
Drug: Dental gel
RxNorm normalized name: DENTAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental gel
Trial: 2530547
Drug: Cefixime 400
RxNorm normalized name: cefixime 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 400 mg/day (single daily dose)
Trial: 2530547
Drug: Cefixime 400
RxNorm normalized name: cefixime 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 400 mg/day (two divided doses)
Trial: 1190691
Drug: Vasectomy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vasectomy and irrigation of distal vasa with acid Kystosol solution
Trial: 22119995
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) chemotherapy
Trial: 25959002
Drug: Overall chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall chemotherapy (both IV and oral)
Trial: 21726499
Drug: Clindox® 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindox® 150 mg capsule (test)
Trial: 21726499
Drug: Dalacin C®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalacin C® 150 mg capsule (reference)
Trial: 16184460
Drug: Exemestane (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exemestane (25 mg/day)
Trial: 16707074
Drug: New atypical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New atypical drugs
Trial: 16707074
Drug: New atypical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New atypical drugs (band 2)
Trial: 15531010
Drug: 4 NaP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 NaP tablets (1.5 g NaP/tablet) each morning for 28 days (group A)
Trial: 15531010
Drug: 8 NaP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 NaP tablets (1.5 g NaP/tablet) each morning for 28 days (group B)
Trial: 25907673
Drug: Droxidopa (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droxidopa (200 to 600 mg TID)
Trial: 25907673
Drug: Droxidopa plus
RxNorm normalized name: Droxidopa
DrugBank: Droxidopa (DB06262)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Droxidopa plus Carbidopa (25 or 50 mg TID)
Trial: 25907673
Drug: Co-treatment (Droxidopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-treatment (Droxidopa + Carbidopa)
Trial: 21173013
Drug: Anakinra (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra (2 mg/kg subcutaneous daily, maximum 100 mg)
Trial: 12563620
Drug: Neoral (cyclosporine)
RxNorm normalized name: cyclosporine Oral Capsule [Neoral]
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoral (cyclosporine) with olestra (0.35 g/kg, max 16 g)
Trial: 10694769
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral iron supplementation (2-3 mg of elemental iron per kg of body weight) for 3 months
Trial: 9181765
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment (group II)
Trial: 8451344
Drug: Rational-Emotive Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rational-Emotive Therapy
Trial: 8451344
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Rational-Emotive Therapy + Auditory subliminal stimulation)
Trial: 3488384
Drug: 1000 IU
RxNorm normalized name: D 1000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 IU vitamin D3 daily (group +D)
Trial: 26584454
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg Careless™
Trial: 26584454
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg Careless™
Trial: 26584454
Drug: Careless™ (3000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Careless™ (3000 µg/mL)
Trial: 26584454
Drug: Careless™ (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Careless™ (1500 µg/mL)
Trial: 26584454
Drug: Careless™ (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Careless™ (300 µg/mL)
Trial: 23534775
Drug: Granisetron injection
RxNorm normalized name: granisetron Injection
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron injection as primary prophylaxis
Trial: 21221620
Drug: Intratympanic dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intratympanic dexamethasone injection (ITDI) - 4 sequential injections within 2 weeks after systemic steroids
Trial: 21221620
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group - no further medications after systemic steroids
Trial: 14664881
Drug: Arimidex (anastrozole)
RxNorm normalized name: anastrozole Oral Tablet [Arimidex]
DrugBank: Anastrozole (DB01217)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Arimidex (anastrozole) alone or in combination with tamoxifen
Trial: 8776638
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin management (100 IU/kg i.v. and 0 to 1,000 IU/L priming; target ACT over 180 seconds)